• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Namesensor, glucose, invasive
Generic Namesensor, glucose, invasive
965 chesterbrook blvd.
wayne, PA 19087
PMA NumberP130007
Supplement NumberS004
Date Received04/30/2015
Decision Date12/24/2015
Product Code
MDS[ Registered Establishments with MDS ]
Docket Number 16M-0120
Notice Date 02/12/2016
Advisory Committee Clinical Chemistry
Supplement Typepanel track
Supplement Reason labeling change - indications/instructions/shelf life/tradename
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the animas vibe system. The animas® vibe system consists of the animas vibe insulin pump paired with the dexcom g4 platinum cgm sensor and transmitter. The animas vibe insulin pump is intended for the continuous subcutaneous infusion of insulin for the management of insulin-requiring diabetes. It can be used solely for continuous insulin delivery or as part of the animas vibe system to receive and display continuous glucose measurements from the dexcom g4 platinum sensor and transmitter. The animas vibe systems continuous glucose monitoring (cgm) is indicated for detecting trends and tracking patterns in persons (age 2 and older) with diabetes, and is intended to complement, not replace, information obtained from standard home glucose monitoring devices. Cgm aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long term therapy adjustments, which may minimize these excursions. Interpretation of results from the dexcom g4 platinum sensor and transmitter should be based on the trends and patterns seen with several sequential readings over time. The animas vibe system is intended for single patient use in persons age 2 and older and requires a prescription.
Approval Order Approval Order
Summary Summary of Safety and Effectiveness
Labeling Labeling